Amazing how Lipitor sales trajectory jumped from $2B to $4B in a year’s time even within the very crowded statin market. I believe VASCEPA will have an EPIC launch and we are all severely underestimating its sales potential. I think AMRN management is only planning for epic success, so BP will have to negotiate hard during BO.
  • 3